Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT07493720 (P-Beta-H) for Pregnancy is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood (P-Beta-H) 40
Clinical Trial NCT07493720 (P-Beta-H) is an observational study for Pregnancy and is currently not yet recruiting. Enrollment is planned to begin on 1 July 2026 and continue until the study accrues 40 participants. Led by University of Nebraska, this study is expected to complete by 1 December 2026. The latest data from ClinicalTrials.gov was last updated on 25 March 2026.
Brief Summary
The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood.
Detailed Description
The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood. This data will help the investigator compare trending levels of beta-hCG levels in pregnant patients between venous blood vs peripheral blood which may help determine levels at which the peripheral blood may no longer be detectable on a POC pregnancy test...Show More
Official Title
Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood
Conditions
PregnancyPublications
Scientific articles and research papers published about this clinical trial:Other Study IDs
- P-Beta-H
- 0843-25-EP
NCT ID Number
Start Date (Actual)
2026-07
Last Update Posted
2026-03-25
Completion Date (Estimated)
2026-12
Enrollment (Estimated)
40
Study Type
Observational
Status
Not yet recruiting
Keywords
pregnancy
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
Cohort 1 19 years of age or older, positive pregnancy status | Beta-hCG Enrolled participants will provide 2 serum specimens (venipuncture and peripheral finger stick) for beta-hCG testing |
Primary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Beta-hCG value | Venipuncture and peripheral finger stick serum will be tested for beta-hCG levels. | Once on date of enrollment |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
19 Years
Eligible Sexes
Female
19 years of age, positive pregnant status recorded in EMR, presenting to Nebraska Medicine OB/GYN clinic -
No meeting the inclusion criteria
-
Study Responsible Party
Thanh Nguyen, Principal Investigator, Assistant Professor, University of Nebraska
Study Central Contact
Contact: Thanh Nguyen, PhD, 14025597884, [email protected]
1 Study Locations in 1 Countries
Nebraska
University of Nebraska Medical Center, Omaha, Nebraska, 68198-1150, United States
Thanh Nguyen, Contact, 4025597884, [email protected]